Author Archives:

Nobilis Therapeutics Signs Exclusive License Agreement with Harvard University for PTSD Treatment.

San Diego, CA, March 29, 2016 — Nobilis Therapeutics, Inc. announced today an entry into an exclusive agreement with Harvard University’s Partners Healthcare to license intellectual property surrounding the use of noble gas-containing mixtures as a treatment for Post-Traumatic Stress Disorder (PTSD). The agreement gives Nobilis Therapeutics the rights to the treatment of PTSD as… Read More »